Abstract
Primary bone lymphoma is a rare condition which represents a low percentage of both the malignant primary bone tumours and the non-Hodgkin extranodal lymphoma. This explains the lack of publications, lines of investigations, and specific diagnostic and treatment protocols. In the following article we will carry out a revision of the existing literature on this rare subject, using as argument a clinical case of left femoral location stage IE treated with CHOP chemotherapy and radiotherapy.
Similar content being viewed by others
References
Parker F, Jackson H Jr. Primary reticulum cell sarcoma of bone. Surg Gynecol Obstet. 1939;68:45–53.
Oberling C. Les reticulosarcomes et les reticuloendothelisarcomes de la moelle osseuse (sarcomes d'Ewing). Bull Assoc Fr Ëtude Cancer (Paris). 1928;17:259–96.
Ewing J. General pathology of lymphosarcoma. Bull N York Acad Med. 1959;15:92–103.
Boston HC Jr, Dahlin DC, Ivins JC, Cupps RE. Malignat Lymphoma (so-called retic sarcoma) of bone. Cancer. 1974;54(4):1131–7.
Freeman C, Berg JW, Cutter SJ. Ocurrence and prognosis of extranodal lymphomas. Cancer. 1972;29:252–60.
Rosenberg SA, Diamond HD, Jaslowitz B, Craver LF. Lymphosarcoma: A review of 1,269 cases. Medicine. 1961;40:51–81.
Rudder RA, Ross ME, Delellis RA. Primary extranodal lymphoma response to treatment and factors influencing prognosis. Cancer. 1978;42:406–16.
Salter M, Sollacio RJ, Bernreuter WK, Weppelmann B. Primary lymphoma of bone: the use of MRI in pretreatment evaluation. Am J Clin Oncol. 1989;12:101–5.
Baar J, Burkes RL, Bell R, Blackstein ME, Fernandes B, Langer F. Primary Non-Hodgkin's Lymphoma of bone. A clinicopathologic study. Cancer. 1994;75:1194–9.
Fairbanks RK, Bonner JA, Inwards CY, et al. Treatment of stage IE primary lymphoma of bone. Int J Radiat Oncol Biol Phys. 1994;28(2):565–72.
Fidias P, Spiro I, Sobczak ML, et al. Longterm results of combined modality therapy in primary bone lymphomas. Int J Radiat Oncol Biol Phys. 1999;45(5):1215–8.
Zinzani PL, Carrillo G, Ascani S, et al. Primary bone lymphoma: experience with 52 patients. Haematologica. 2003;88: 280–5.
Dubey P, Ha CS, Besa PC, et al. Localized primary malignant lymphoma of bone. Int J Radiat Oncol Biol Phys. 1997;37(5): 1087–93.
Lewis VO, Primus G, Anastasi J, et al. Oncologic outcomes of primary lymphoma of bone in adults. Clin Orthop Relat Res. 2003;415:90–7.
Someya M, Sakata K, Nagakura H, et al. Three cases of diffuse large B-cell lymphoma of the mandible treated with radiotherapy and chemotherapy. Radiat Med. 2005;23(4):296–302.
Horning SJ, Weller E, Kim K, et al. Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1,484. J Clin Oncol. 2004;22(15):3052–8.
Miller TP, Dahlberg S, Cassady JR, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med. 1998;539:21–6.
Ohgi S, Ehara S, Satoh T, et al., Spontaneous regression of malignant lymphoma of the lumbar spine. Skeletal Radiol. 2002; 31(2):99–102.
Savage DG, Staron R. Rituximab for bone lymphoma. Ann Intern Med. 2001;134 (12):1156–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sánchez, C.M., Hebrero, M.L., Mesa, C. et al. Primary bone lymphoma. Clin Transl Oncol 8, 221–224 (2006). https://doi.org/10.1007/s12094-006-0015-y
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s12094-006-0015-y